To improve the prognosis of patients suffering from pulmonary diseases, such as lung cancer, early diagnosis and treatment are crucial. The analysis of CT images is invaluable for diagnosis, whereas high quality segmentation of the airway tree are required for intervention planning and live guidance during bronchoscopy. Recently, the Multi-domain Airway Tree Modeling (ATM’22) challenge released a large dataset, both enabling training of deep-learning based models and bringing substantial improvement of the state-of-the-art for the airway segmentation task. The ATM’22 dataset includes a large group of COVID’19 patients and a range of other lung diseases, however, relatively few patients with severe pathologies affecting the airway tree anatomy was found. In this study, we introduce a new public benchmark dataset (AeroPath), consisting of 27 CT images from patients with pathologies ranging from emphysema to large tumors, with corresponding trachea and bronchi annotations. Second, we present a multiscale fusion design for automatic airway segmentation. Models were trained on the ATM’22 dataset, tested on the AeroPath dataset, and further evaluated against competitive open-source methods. The same performance metrics as used in the ATM’22 challenge were used to benchmark the different considered approaches. Lastly, an open web application is developed, to easily test the proposed model on new data. The results demonstrated that our proposed architecture predicted topologically correct segmentations for all the patients included in the AeroPath dataset. The proposed method is robust and able to handle various anomalies, down to at least the fifth airway generation. In addition, the AeroPath dataset, featuring patients with challenging pathologies, will contribute to development of new state-of-the-art methods. The AeroPath dataset and the web application are made openly available.
Background: Minimizing the time until start of cancer treatment is a political goal. In Norway, the target time for lung cancer is 42 days. The aim of this study was to identify reasons for delays and estimate the effect on the timelines when applying an optimal diagnostic pathway. Methods: Retrospective review of medical records of lung cancer patients, with stage I-II at baseline CT, receiving curative treatment (n = 100) at a regional cancer center in Norway. Results: Only 40% started treatment within 42 days. The most important delays were late referral to PET CT (n = 27) and exercise test (n = 16); repeated diagnostic procedures because bronchoscopy failed (n = 15); and need for further investigations after PET CT (n = 11). The time from referral to PET CT until the final report was 20.5 days in median. Applying current waiting time for PET CT (≤7 days), 48% would have started treatment within 42 days (p = 0.254). “Optimal pathway” was defined as 1) referral to PET CT and exercise test immediately after the CT scan and hospital visit, 2) tumor board discussion to decide diagnostic strategy and treatment, 3) referral to surgery or curative radiotherapy, 4) tissue sampling while waiting to start treatment. Applying the optimal pathway, current waiting time for PET CT and observed waiting times for the other procedures, 80% of patients could have started treatment within 42 days (p < 0.001), and the number of tissue sampling procedures could have been reduced from 112 to 92 (− 16%). Conclusion: Changing the sequence of investigations would significantly reduce the time until start of treatment in curative lung cancer patients at our hospital and reduce the resources needed.
27 September 2010 in Minimally Invasive Therapy & Allied Technologies
Electromagnetic guided bronchoscopy is a new field of research, essential for the development of advanced investigation of the airways and lung tissue. Consecutive problem-based solutions and refinements are urgent requisites to achieve improvements. For that purpose, our intention is to build a complete research platform for electromagnetic guided bronchoscopy. The experimental interventional electromagnetic field tracking system in conjunction with a C-arm cone beam CT unit is presented in this paper. The animal model and the navigation platform performed well and the aims were achieved; the 3D localization of foreign bodies and their navigated and tracked removal, assessment of tracking accuracy that showed a high level of precision, and assessment of image quality. The platform may prove to be a suitable platform for further research and development and a full-fledged electromagnetic guided bronchoscopy navigation system. The inclusion of the C-arm cone beam CT unit in the experimental setup adds a number of new possibilities for diagnostic procedures and accuracy measurements. Among other future challenges that need to be solved are the interaction between the C-arm and the electromagnetic navigation field, as we demonstrate in this feasibility study.
1 October 2011 in Journal of Bronchology & Interventional Pulmonology
Current image guidance systems for bronchoscopy are limited to the diagnosis of small tumors and placing fiducials for radiation therapy and surgery. Ideally, a navigation system should be useable for the range of bronchoscopic procedures, including therapy with concurrent radiology imaging for control. As most guidance systems rely on electromagnetic (EM) fields, it is advised to leave the C-arm mounted fluoroscopy unit outside the operating field during navigation. We have assessed the accuracy of our research navigation platform, containing an EM field generator and a C-arm fluoroscopy unit. We have simulated a regular bronchoscopy session with an initial image-to-patient registration procedure, and a subsequent bronchoscopy with the C-arm inside the EM field. The registration accuracy was significantly influenced, introducing an error that may be carried through to the bronchoscopy procedure. During the bronchoscopy session, the C-arm caused a wave drift in the tracking positions and distorted the EM field, causing a translation error up to 22 mm. Even by averaging out the drift, there was a systematic shift in the x, y, and z positions. The errors were more evident in some C-arm positions and seem to be linked more to the electrical current in the fluoroscopy unit than the metallic C-arm itself. A fluoroscopy unit may be used during a navigation procedure, but care must be taken. To enable real-time navigation, the C-arm could be removed sufficiently from the EM tracking field or correction schemes must be implemented to compensate for the distortions.
Endobronchial ultrasound (EBUS) is used in the minimally invasive sampling of thoracic lymph nodes. In lung cancer staging, the accurate assessment of mediastinal structures is essential but challenged by variations in anatomy, image quality, and operator-dependent image interpretation. This study aimed to automatically detect and segment mediastinal lymph nodes and blood vessels employing a novel U-Net architecture-based approach in EBUS images. A total of 1161 EBUS images from 40 patients were annotated. For training and validation, 882 images from 30 patients and 145 images from 5 patients were utilized. A separate set of 134 images was reserved for testing. For lymph node and blood vessel segmentation, the mean ± standard deviation (SD) values of the Dice similarity coefficient were 0.71 ± 0.35 and 0.76 ± 0.38, those of the precision were 0.69 ± 0.36 and 0.82 ± 0.22, those of the sensitivity were 0.71 ± 0.38 and 0.80 ± 0.25, those of the specificity were 0.98 ± 0.02 and 0.99 ± 0.01, and those of the F1 score were 0.85 ± 0.16 and 0.81 ± 0.21, respectively. The average processing and segmentation run-time per image was 55 ± 1 ms (mean ± SD). The new U-Net architecture-based approach (EBUS-AI) could automatically detect and segment mediastinal lymph nodes and blood vessels in EBUS images. The method performed well and was feasible and fast, enabling real-time automatic labeling.
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a cornerstone in minimally invasive thoracic lymph node sampling. In lung cancer staging, precise assessment of lymph node position is crucial for clinical decision-making. This study aimed to demonstrate a new deep learning method to classify thoracic lymph nodes based on their anatomical location using EBUS images. Bronchoscopists labeled lymph node stations in real-time according to the Mountain Dressler nomenclature. EBUS images were then used to train and test a deep neural network (DNN) model, with intraoperative labels as ground truth. In total, 28,134 EBUS images were acquired from 56 patients. The model achieved an overall classification accuracy of 59.5 ± 5.2%. The highest precision, sensitivity, and F1 score were observed in station 4L, 77.6 ± 13.1%, 77.6 ± 15.4%, and 77.6 ± 15.4%, respectively. The lowest precision, sensitivity, and F1 score were observed in station 10L. The average processing and prediction time for a sequence of ten images was 0.65 ± 0.04 s, demonstrating the feasibility of real-time applications. In conclusion, the new DNN-based model could be used to classify lymph node stations from EBUS images. The method performance was promising with a potential for clinical use.